3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009

SHENYANG, China, Oct. 27 3SBio Inc. (Nasdaq:SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology companyfocused on researching, developing, manufacturing and marketingbiopharmaceutical products, today announced that it will release financialresults for the third quarter ended September 30, 2009 after the US marketcloses on Thursday, November 12, 2009.

Following the earnings announcement, 3SBio's senior management will host aconference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 9:00 pm(Beijing/Hong Kong) on Friday, November 13, 2009 to discuss its 2009 thirdquarter financial results and recent business activity. The conference callmay be accessed using the dial-in numbers below:

A telephone replay will be available two hours after the call untilNovember 20, 2009, at:

Webcast

A live webcast of the conference will be available on the investorrelations page of 3SBio's website athttp://bbs.3sbio.com/en/News/xinvestors.aspx and athttp://tinyurl.com/yf93ntk . A replay of the webcast will be available withinone hour after the conclusion of the call.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China. For more information, please visit 3SBio on theweb at http://www.3sbio.com .Conference ID: 38479039 Local dial-in: China - landline 800-819-0121 China - mobile 400-620-8038 International toll-free dial-in: Hong Kong 800930346 United Kingdom 080-8234-6646 United States 1-866-519-4004 International toll dial-in: 65-6735-7955 Replay-Conference ID: 38479039

SOURCE 3SBio Inc.

Latest Press Release on General News

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...

Dr. Andres Bustillo Responds to Miami's Growing Interest in Facelift Procedures

In response to the growing demand for facelifts in Miami , Dr. Andres Bustillo , a renowned board-certified facial plastic surgeon, is offering advanced and time-proven techniques in f...